Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making
Published 2009 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oral antipsychotics for the treatment of schizophrenia: heterogeneity in efficacy and tolerability should drive decision-making
Authors
Keywords
-
Journal
EXPERT OPINION ON PHARMACOTHERAPY
Volume 10, Issue 12, Pages 1917-1928
Publisher
Informa Healthcare
Online
2009-06-29
DOI
10.1517/14656560903061309
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Special Section on Implications of CATIE: What CATIE Found: Results From the Schizophrenia Trial
- (2014) Marvin S. Swartz et al. PSYCHIATRIC SERVICES
- Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
- (2010) Hong Liu-Seifert Neuropsychiatric Disease and Treatment
- Quetiapine
- (2009) Leslie Citrome CNS DRUGS
- Pharmacotherapy of patients with schizophrenia and substance abuse
- (2009) Thomas Wobrock et al. EXPERT OPINION ON PHARMACOTHERAPY
- The Impact of Calories and Fat Content of Meals on Oral Ziprasidone Absorption
- (2009) Kuan Gandelman et al. JOURNAL OF CLINICAL PSYCHIATRY
- Is Flunarizine a Long-Acting Oral Atypical Antipsychotic?
- (2009) Luisa W. Bisol et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Longitudinal Study of Medication Nonadherence and Hospitalization Risk in Schizophrenia
- (2009) Michael R. Law et al. JOURNAL OF CLINICAL PSYCHIATRY
- All Antipsychotics Are Equal, but Some Are More Equal Than Others
- (2009) JOURNAL OF CLINICAL PSYCHIATRY
- Standard and Higher Dose of Olanzapine in Patients With Schizophrenia or Schizoaffective Disorder
- (2009) Bruce J. Kinon et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- A Meta-Analysis of Head-to-Head Comparisons of Second-Generation Antipsychotics in the Treatment of Schizophrenia
- (2008) Stefan Leucht et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effectiveness of second generation antipsychotics: A systematic review of randomized trials
- (2008) Erik Johnsen et al. BMC Psychiatry
- Do effectiveness (“real world”) studies on antipsychotics tell us the real truth?
- (2008) Hans-Jürgen Möller EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
- Olanzapine: review of safety 2008
- (2008) Joshua T Kantrowitz et al. Expert Opinion On Drug Safety
- Interpreting and applying the EUFEST results using number needed to treat: antipsychotic effectiveness in first-episode schizophrenia
- (2008) L. Citrome INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Are all antipsychotics equal?
- (2008) Jan Volavka LANCET
- Are all antipsychotics equal? – Authors' reply
- (2008) René S Kahn et al. LANCET
- Pharmacotherapy of first-episode schizophrenia
- (2008) Robert A Rosenheck LANCET
- Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial
- (2008) René S Kahn et al. LANCET
- Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis
- (2008) Stefan Leucht et al. LANCET
- How effective are second-generation antipsychotic drugs? A meta-analysis of placebo-controlled trials
- (2008) S Leucht et al. MOLECULAR PSYCHIATRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started